Chemours Announces Dates for Fourth Quarter 2025 Earnings Release and Webcast Conference Call

WILMINGTON, Del., Feb. 4, 2026 /PRNewswire/ -- The Chemours Company ("Chemours" or "the Company") (NYSE: CC) today announced that the Company expects to issue its fourth quarter 2025 financial results after market on Thursday, February 19, 2026.

PRNewsWire • Feb 4, 2026

Chemours: Upside More Confirmed In 2026E

Chemours is reiterated as a 'Buy' with a $20 PT and fair value up to $30, reflecting cyclical upside and improved visibility. CC's Opteon refrigerants and Advanced Performance Materials segments are key growth drivers, offsetting legacy Titanium Tech and PFAS liability risks. Despite high leverage and ongoing PFAS settlements, CC maintains strong liquidity and expects $120M in cost savings by 2025.

Seeking Alpha • Jan 29, 2026

CC to Sell Former Titanium Dioxide Taiwan Site Land for $360M

CC agrees to sell its former Taiwan titanium dioxide site land for about $360M, aiming to cut debt as part of its portfolio and balance-sheet optimization.

Zacks Investment Research • Jan 16, 2026

The Chemours Company Agrees to Sell Former Titanium Dioxide Site in Taiwan

WILMINGTON, Del., Jan. 15, 2026 /PRNewswire/ -- The Chemours Company ("Chemours" or "the Company") (NYSE: CC), a global chemistry company with leading market positions in Thermal & Specialized Solutions ("TSS"), Titanium Technologies ("TT"), and Advanced Performance Materials ("APM"), today signed a set of definitive agreements to sell the remaining land1 at its former titanium dioxide manufacturing location in Kuan Yin, Taiwan to an ownership group including Century Wind Power Co., Ltd.

PRNewsWire • Jan 15, 2026

Hagens Berman: Montana Court Denies Motions to Dismiss Class-Action Lawsuit Fighting PFAS in Firefighter Turnout Gear

BUTTE, Mont.--(BUSINESS WIRE)---- $CC #3M--A Montana federal judge denied motions to dismiss a class-action lawsuit brought by Hagens Berman to combat toxic PFAS in firefighter turnout gear.

Business Wire • Jan 6, 2026

This Chemicals Stock Is Down 32% but Just Became a Top 5 Holding After One Fund's $13 Million Bet

New York City-based Alta Fundamental Advisers initiated a new position in Chemours Company during the third quarter. The fund reported 800,000 shares acquired with a net position change estimated at $12.67 million.

The Motley Fool • Dec 22, 2025

Chemours Appoints Michael Foley as President of Titanium Technologies; Announces Departure of Damián Gumpel

WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Chemours Appoints Michael Foley as President of Titanium Technologies; Announces Departure of Damián Gumpel.

Business Wire • Dec 4, 2025

This Fund Bought $63 Million of Chemours Stock Even as Shares Sit 80% Below 2017 Highs

New York City-based Cooper Creek Partners bought nearly 4 million shares of The Chemours Company in the third quarter. The shares were worth about $63.1 million at the end of the quarter.

The Motley Fool • Nov 30, 2025

Chemours Q3 Earnings Lag Estimates Amid Operational Disruptions

CC posts a Q3 profit rebound with $60M in net income, driven by strong Thermal & Specialized Solutions amid mixed segment results.

Zacks Investment Research • Nov 11, 2025

Chemours: Solid Momentum Despite One-Time Costs In Q3

Chemours remains challenged by weak end markets, but progress on environmental liabilities and Opteon growth support medium-term prospects. Q3 results were mixed, with disruptions impacting earnings, but the resolution of outages and Opteon gains in the TSS segment provide optimism for improvement. TT segment struggles with weak construction activity, but price increases and supply rationalization should help results bottom in 6–9 months.

Seeking Alpha • Nov 11, 2025